News

SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced to launch Bivalirudin…
Read More...

Sartorius Stedim Biotech (SSB) launched a new vessel for its ambr 250 modular benchtop automated mini bioreactor system. The single-use vessel has been specially designed for…
Read More...

Liquidia Technologies announced that it has amended its collaboration agreement with GlaxoSmithKline (GSK) for the development and commercialization of pharmaceuticals based upon the…
Read More...

Mölnlycke and Zuellig Pharma have announced a new partnership that will focus on providing more advanced wound care products and solutions to patients and healthcare practitioners…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for use with other medicines to treat chronic…
Read More...

Oxford BioTherapeutics Ltd. announced that it has received a milestone payment from Boehringer Ingelheim (BI). In addition to OBT’s two clinical stage assets, MEN1309/OBT076 and…
Read More...

Akorn, Inc. announced that it received a warning letter from the U.S. Food and Drug Administration (FDA) related to the inspection of its Somerset, New Jersey manufacturing facility in…
Read More...

Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., announced it is advancing its novel, potentially first-in-class…
Read More...

C4X Discovery Holdings plc, a pioneering drug discovery company, entered into a collaboration with PhoreMost, a UK-based biopharmaceutical company dedicated to drugging ‘undruggable’…
Read More...

Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary…
Read More...

Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet…
Read More...

Rafael Pharmaceuticals announced that it has entered into an out-licensing agreement with Ono Pharmaceutical Co., Ltd. (“Ono”), a pharmaceutical company committed to creating innovative…
Read More...

AbbVie Inc. and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction…
Read More...

The European Investment Bank (EIB) has taken a further step forward in fostering innovation in the Spanish and European pharmaceutical sector. By granting a €120 MM loan to Almirall…
Read More...

Clinigen Group plc announces that its Commercial Medicines business has signed an exclusive agreement with Accord Healthcare (‘Accord’) to supply and distribute Clinigen’s speciality…
Read More...

Prestige BioPharma (herein, Prestige) announced positive top-line results from a Phase III global clinical trial (Troika) evaluating the efficacy, safety, and pharmacokinetics (PK) of…
Read More...

Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule…
Read More...

GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases,…
Read More...

Arrowhead Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ARO-APOC3 for the treatment of familial chylomicronemia…
Read More...

Sanofi and Regeneron Pharmaceuticals announced that a Phase 2 proof-of-concept trial evaluating the investigational IL-33 antibody REGN3500 (SAR440340) met the primary endpoint of…
Read More...